GPT and metabolic dysfunction-associated steatotic liver disease: Although these studies emphasize the correlation of the ALT/AST ratio with NAFLD risk, they were all cross-sectional in design, and the sample sizes were relatively small (1222, 1354, 6926 and 10,724).